Access to treatment and medication for opioid use disorder (MOUD) is essential for reducing HIV and HCV transmissions. However, the spatial distribution of the resources for treatment and medication is a result of various social factors, which can include potential inequities.
To demonstrate the utility of a spatial perspective in evaluating access to MOUD resources, The University of Chicago and Argonne National Laboratory will use a simulation approach to evaluate how treatment and intervention locations affect HIV and HCV transmissions. This study will also evaluate interventions using scenarios of varying levels of spatial inequity in HepCEP, a validated agent-based model (ABM) for Hepatitis C Elimination in Persons Who Inject Drugs (PWID). Outcomes from this study may provide insight into the complex factors that drive MOUD treatment heterogeneity within communities using more spatialized approaches for evaluation of efficacy.
- Modeling the impact of spatial inequities in access to medications for treatment of opioid use disorder among persons who inject drugs (2023)
- Stimulant use interventions may strengthen ‘Getting to Zero’ HIV elimination initiatives in Illinois: Insights from a modeling study (2022)
- Factors associated with HIV testing and treatment among young Black MSM and trans women in three jail systems (2023)
- “I feel like marijuana is the only drug that wouldn’t kill me”: perceptions of cannabis use in previously incarcerated Black men who have sex with other men (2023)
- Impact of post-incarceration care engagement interventions on HIV transmission among young Black men who have sex with men and their sexual partners: An agent-based network modeling study (2023)
PI: Marynia Kolak, Jonathan Ozik
• Assess the utility of a spatial perspective in evaluating access to MOUD resources
• Examine how shifts in MOUD locations impact upstream health outcomes for persons who inject drugs